Navigation Links
Multiferon Shows Potent Activity in Preventing the Progression of,Malignant Melanoma; Study to be Published

terferon drug products in that it contains a unique mixture of multiple subtypes of human interferon (a1, a2, a8, a10, a14, a21). It is believed that each subtype, some of which are glycosylated, employs a specific biological activity, but more importantly, the subtypes act synergistically to elicit an overall effect.

For prescription information, please visit: http://www.Multiferon.com

About Viragen, Inc.:

With international operations in the U.S., Scotland and Sweden, we are a bio-pharmaceutical company engaged in the research, development, manufacture and commercialization of therapeutic proteins for the treatment of cancers and viral diseases. Our product portfolio includes: Multiferon(R) (multi- subtype, human alpha interferon) which is uniquely positioned in valuable niche indications, such as high-risk malignant melanoma, and other select cancers and infectious diseases; VG102, a novel monoclonal antibody that binds selectively to an antigen that is significantly over-expressed on nearly all malignant tumors; and VG106, a novel cytokine targeting difficult-to-treat cancers. We are also pioneering the development of The OVA(TM) System with the renowned Roslin Institute, creators of "Dolly the Sheep", as a revolutionary manufacturing platform for the large-scale, efficient and economical production of human therapeutic proteins and antibodies, by expressing these products in the egg whites of transgenic hens.

          For more information, please visit: http://www.Viragen.com


    Viragen, Inc. Corporate Contact:

    Douglas Calder, Director of Communications

    Phone: (954) 233-8746; Fax: (954) 233-1414

    E-mail: 

dcalder@viragen.com

The foregoing press announcement contains forward-looking statements that can be identified by such terminology s
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:7/29/2015)... July 29, 2015   KaloBios Pharmaceuticals, Inc . ... on developing innovative therapies to benefit patients with diseases ... announced today that the U.S. Food and Drug Administration ... application for KB003, an anti-GM-CSF monoclonal antibody (mAb), in ... IND is now active. The acceptance of ...
(Date:7/29/2015)... , July 29, 2015  The Perinatal ... to improve understanding of the advantages, limitations and ... screening and other diagnostic tests for pregnant women ... DGX ), the world,s leading provider of diagnostic ... support the initiative, through a grant. ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today ... a national broadcast news segment in Australia ... following regulatory and reimbursement approval in that country. ... 1.2 million Australians living with diabetes. As a case in ... great solution for a 13 year old boy with Type ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
... N.C., Nov. 29, 2011 Campbell Alliance, an inVentiv ... specializing in the pharmaceutical and biotech industry, today ... 10 Most Licensable Oncology Projects to Watch.  Selected ... the upcoming Windhover Therapeutic Area Partnerships conference ( ...
... WELLESLEY HILLS, Mass., Nov. 29, 2011  Joseph F. Finn, ... of Epix Pharmaceuticals, Inc. ("Epix") announced today that AMG ... the S1P1 lead compounds will be offered December 8, ... generated by Epix Pharmaceuticals, Inc. and Amgen. ...
Cached Medicine Technology:Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011 2Campbell Alliance Announces Windhover Top 10 Oncology Projects for 2011 3AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen. 2
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named ... Health division. In her position, Ramkeesoon will help build and expand work ... Ramkeesoon spent close to a decade at ICF International, most recently as a ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and ... for nearly 38 years, is motivated each and every day by his sincere desire ... shine alongside his many awards and accolades, which include multiple listings in many highly ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today the nonprofit ... Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the ... government, and health care experts can improve patient compliance. , Although influenza, pneumococcal, ...
(Date:7/29/2015)... ... 29, 2015 , ... " Core Organizer ” was featured on NewsWatch as ... applications on the market for iOS, Android, and Windows. Joe Toohey, the host of ... app will help anyone get organized. , Wouldn’t it be great if everyone could ...
(Date:7/29/2015)... ... July 29, 2015 , ... Angelo’s FabriClean, an area rug cleaning company in ... of carpets and rugs. The company will now reverse the damage caused by water ... An overflowing overhead tank, rain leaking through an accidently left open window or a ...
Breaking Medicine News(10 mins):Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Get More Organized with the Core Organizer App 2Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2
... and Palm,Beach will be joined by a third, CyberKnife ... Miami, a world renowned image guided robotic radiosurgery,practice facilitator, ... community-based outpatient cancer treatment facilities. The mission of,MORSE LLC ... number of,patients and physicians. A fourth center is in ...
... AMSTERDAM, The Netherlands, July 14 , - ... Years, Elsevier, a leading publisher of scientific, ... online scientific research,platform, ScienceDirect, has surpassed nine million ... than five years, ScienceDirect is the,largest and most ...
... VICL ) today announced the scheduled presentation ... Phase 1 trial of the company,s,Vaxfectin(R)-formulated H5N1 pandemic ... IBC Life Sciences Next Generation Vaccines conference,(National Harbor, ... of Vaccine Research, Larry R. Smith, Ph.D., will,present ...
... the cooler weather, many young,adults continue to wear slides, ... Brands -- in the locker room, on campus, in,the ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080714/NYFNSP09 ), But, according to ... 30 years in western Wisconsin and member of the ...
... computing solutions provider recognized by one of the most "wired" ... ... Columbus, OH (PRWEB) July 14, 2008 -- Artromick provides accurate ... computing and medical cart equipment. In today's demanding world of ...
... ... life, SAN DIEGO, July 13 ... (NCLR) to unveil a small,tool aimed at battling a big problem -- chronic ... Vida --,Su Guia de Recursos de Salud, with the support of NCLR during ...
Cached Medicine News:Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 2Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 3Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 2Health News:Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines 3Health News:Choose Flip Flops Carefully for Back to School, Say Chiropractors 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4
ELISA for the detection of Insulin....
... (17alpha-OH-P) is a steroid produced in the ... defined physiological role except as a precursor ... be converted to cortisol by the sequential ... the adrenal glands and ovaries, 17alpha-OH-P can ...
... PC1200 Platelet Incubators bring ... laboratory counter top. These compact ... to have the security of ... without taking up a large ...
The PC4200i is the largest capacity platelet incubator available. It features a built-in agitator with a capacity of 396 random bags (132 apheresis)....
Medicine Products: